首页> 外文期刊>Analytical and bioanalytical chemistry >Consecutive and automatic detection of multi-gene mutations from colorectal cancer samples by coupling droplet array-based capillary electrophoresis and PCR-RFLP
【24h】

Consecutive and automatic detection of multi-gene mutations from colorectal cancer samples by coupling droplet array-based capillary electrophoresis and PCR-RFLP

机译:通过耦合液滴阵列基毛细管电泳和PCR-RFLP,连续和自动检测与结肠直肠癌样品中的多基因癌样品

获取原文
获取原文并翻译 | 示例
           

摘要

The efficacy of targeted therapy is associated with multi-gene mutation status. Carrying out effective multi-genotyping analysis in combination has been a challenge in clinical settings. We therefore developed a droplet-based capillary electrophoresis (CE) system coupled with PCR-restriction fragment length polymorphism (PCR-RFLP) technology to detect multi-gene mutations from a small volume of samples. A 16?×?16 200-nL droplet array for sample encapsulation was constructed on a glass chip. The electrophoresis system consisted of a tapered vertical capillary filled with polyvinylpyrrolidone, a laser-induced fluorescence detector, and a high voltage power supply. Notably, a droplet-based electrokinetic sample introduction method and a “∩” shape capillary were developed to facilitate consecutive droplet sampling using a home-made automatic control module. The DL2000 DNA marker was consecutively separated, achieving high migration time and plate number reproducibility. The system was further applied to detect PCR-RFLP products. For colorectal cancer (CRC) cell lines, KRAS, BRAF, and PIK3CA were genotyped with a sensitivity of 0.25%. For CRC patient specimens, 30 samples were consecutively and automatically multi-genotyped without inter-sample contamination, with a lowest mutation frequency of 0.37%. For the first time, we developed a droplet-based CE system for consecutive DNA analysis with low sample consumption. This automated CE system could be further developed to integrate the full process of gene mutation detection, serving as a more effective platform for individualised therapy.
机译:靶向治疗的疗效与多基因突变状态有关。培养有效的多基因分型分析组合在临床环境中是挑战。因此,我们开发了一种基于液滴的毛细管电泳(Ce)系统,其与PCR限制性片段长度多态性(PCR-RFLP)技术耦合,以检测来自少量样品的多基因突变。用于样品封装的16?×16 200-NL液滴阵列在玻璃芯片上构建。电泳系统由圆锥形垂直毛细管组成,填充聚乙烯吡咯烷酮,激光诱导的荧光检测器和高压电源。值得注意的是,开发了基于液滴的电动样品引入方法和“∩”形状毛细管,以便使用自制的自动控制模块进行连续液滴采样。在连续分离DL2000 DNA标记,实现高迁移时间和板数再现性。该系统进一步应用于检测PCR-RFLP产品。对于结直肠癌(CRC)细胞系,KRA,BRAF和PIK3CA是基因分型,敏感性为0.25%。对于CRC患者标本,30个样品连续并自动多基因分型而无需采样间污染,突变频率最低为0.37%。我们首次开发了一种基于液滴的CE系统,用于连续的DNA分析,具有低样品消耗。可以进一步开发这种自动化CE系统以整合基因突变检测的全过程,作为个性化治疗的更有效的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号